Drug maker Strides Arcolab today said it is in talks with Ascent Pharmahealth, listed on the Australian Stock Exchange, for acquiring a minority stake in the company.
Ranbaxy Laboratories today said it has failed to get the US health regulator's nod for launching generic version of Flomax, a prostrate drug, thereby missing the opportunity to launch the drug in America with exclusive marketing rights.
Aurobindo Pharma today said it has received a tentative approval from the US drug regulator for manufacturing and marketing of its Nevirapine tablets, used in the treatment of HIV infections.
Drug firm Cadila Healthcare today reported two fold increase in its net profit at Rs 130 crore for the third quarter ended December 31, 2009.
Dr Reddy’s ties up with Transgene for new drug
Drug major Ranbaxy Laboratories today said it has launched a new chemical, Lulifin (Luliconazole), used in the treatment of fungal infection.
Ranbaxy Laboratories will launch parent Daiichi Sankyo's antihypertensive drug Olmesartan Medoxomil in six African countries the companies said on Monday.
Ranbaxy will launch the drug in Kenya Mozambique
Cipla Ltd is in talks with a host of global drug makers, including Pfizer Inc, to supply generic products, a top official of the Indian drug maker said, sending its
Stay informed on our latest news!
